Ipamorelin is a selective growth-hormone secretagogue studied for its clean GH-release profile. It is researched most often for Growth hormone release, Recovery and Body composition. Preclinical and early human pharmacology research. This guide walks through what Ipamorelin is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is Ipamorelin?
Ipamorelin is a selective growth-hormone secretagogue that mimics ghrelin to stimulate GH release. It is often researched in combination with GHRH analogs like CJC-1295 for a more pulsatile release pattern.
Also known as: Growth hormone secretagogue.
How does Ipamorelin work?
Ipamorelin is a selective growth-hormone secretagogue that mimics ghrelin at its receptor to trigger growth-hormone release. It is valued in research for a relatively "clean" profile, with less effect on appetite, cortisol, and prolactin than some older secretagogues.
What is Ipamorelin researched for?
In the research and community discussion, Ipamorelin comes up most often in connection with Growth hormone release, Recovery and Body composition. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Growth hormone release
- Recovery
- Body composition
What does the research actually show?
Preclinical and early human pharmacology research. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting Ipamorelin as a guaranteed treatment is getting ahead of the evidence.
What is Ipamorelin typically stacked with?
In the literature and community discussion, Ipamorelin is most often combined with CJC-1295, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Endocrine-active. Not an approved medication for these uses. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about Ipamorelin
To go deeper, see the Ipamorelin library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where Ipamorelin might fit your goals.
Frequently asked questions
Stimulating growth-hormone release, with interest in recovery and body composition. It is often paired with a GHRH analog like CJC-1295.
Compared with earlier secretagogues, it tends to raise growth hormone with fewer off-target effects on cortisol, prolactin, and hunger in studies.
No, it is not an approved medication for these uses. It is endocrine-active and studied in preclinical and early human pharmacology work.
Not sure if Ipamorelin fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.